X0306 4 2023-01-13 false 0001603756 Axonics, Inc. AXNX 0001359446 Ford Alfred J Jr 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false Chief Commercial Officer Common Stock 2023-01-13 4 M false 8509.00 1.42 A 45282.00 D Common Stock 2023-01-13 4 M false 1899.00 1.63 A 47181.00 D Common Stock 2023-01-13 4 M false 9310.00 25.82 A 56491.00 D Common Stock 2023-01-13 4 M false 16297.00 14.19 A 72788.00 D Common Stock 2023-01-13 4 S false 15292.00 65.8972 D 57496.00 D Common Stock 2023-01-13 4 S false 17108.00 66.6866 D 40388.00 D Common Stock 2023-01-13 4 S false 3615.00 67.1759 D 36773.00 D Stock Option (Right to Buy) 25.82 2023-01-13 4 M false 9310.00 0.00 D 2029-12-12 Common Stock 9310.00 4655.00 D Stock Option (Right to Buy) 14.19 2023-01-13 4 M false 16297.00 0.00 D 2029-01-30 Common Stock 16297.00 0.00 D Stock Option (Right to Buy) 1.63 2023-01-13 4 M false 1899.00 0.00 D 2028-03-30 Common Stock 1899.00 0.00 D Stock Option (Right to Buy) 1.42 2023-01-13 4 M false 8509.00 0.00 D 2027-11-15 Common Stock 8509.00 0.00 D This transaction was executed in multiple trades at prices ranging from $65.05 USD to $66.04 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $66.085 USD to $67.08 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $67.13 USD to $67.215 USD; the price reported above reflects the weighted average sale price. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on December 12, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on December 12, 2023, provided the reporting person remains in continuous service on each vesting date. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on November 15, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of November 15, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. /s/ Dan Dearen, as Attorney-in-Fact for Alfred J. Ford, Jr. 2023-01-18